Ir al menú de navegación principal Ir al contenido principal Ir al pie de página del sitio

Canine Leishmaniosis: tools for diagnosis in veterinary practice in Colombia

Canine Leishmaniosis: tools for diagnosis in veterinary practice in Colombia



Abrir | Descargar

Cómo citar
Acero P, V., Ángel B P., Fonseca B, E., Ferrer, L., & Roura, X. (2015). Canine Leishmaniosis: tools for diagnosis in veterinary practice in Colombia. Revista MVZ Córdoba, 20(3), 4822-4842. https://doi.org/10.21897/rmvz.52

Dimensions
PlumX
Víctor Acero P
Perla Ángel B
Esther Fonseca B
Lluís Ferrer
Xavier Roura

ABSTRACT

The objective of this article is to perform a critical analysis and guide veterinarians in the management of canine Leishmaniosis. A systematic literature review was performed between 2005 and 2014 including scientific papers which take into account experiences and reports of: pathogenesis, diagnosis, clinical presentation, treatment, vaccination, prevention and control strategies. We discuss the different aspects of VL management and aspects that should be taken into account depending on the country, after a patient is suspected or confirmed as positive, including the possibility of euthanasia. We describe the different clinical manifestations of the disease, diagnosis, signs and treatment of canine leishmaniosis. Canine leishmaniosis is present in different parts of the country, therefore it must be considered as a possible differential diagnosis in the veterinary clinic, in patients with dermatological and systemic signs that are compatible with various diseases. In Colombia, the patients diagnosed with cutaneous leishmaniasis could be treated and have a favorable prognosis, whereas in canines with diagnosis of visceral leishmaniasis euthanasia should be considered because of the public health implications.


Visitas del artículo 1676 | Visitas PDF


Descargas

Los datos de descarga todavía no están disponibles.
  1. Vélez ID, Carrillo LM, López L, Rodríguez E, Robledo SM. An Epidemic Outbreak of Canine Cutaneous Leishmaniasis in Colombia Caused by Leishmania braziliensis and Leishmania panamensis. Am J Trop Med Hyg 2012; 86(5):807-811. http://dx.doi.org/10.4269/ajtmh.2012.11-0408
  2. Solano-Gallego L, Miró G, Koutinas A, Cardoso L, Grazia MP, Ferrer L, et al. LeishVet guidelines for the practical management of canine leishmaniosis. Parasites & Vectors 2011; 4:86. http://dx.doi.org/10.1186/1756-3305-4-86
  3. Ribeiro AS, Melo MN. Non-Invasive Molecular Diagnosis of Canine Visceral Leishmaniasis Using Conjunctival Swab Samples. En: Claborn D. Leishmaniasis-Trends in Epidemiology, Diagnosis and Treatment. InTech. 2014. 195-216.
  4. Salomón OD, Mastrángelo AV, Santini MS, Ruvinsky S, Orduna T, Sinagra A, et al. Leishmaniasis visceral: senderos que confluyen, se bifurcan. Salud Colectiva 2012; 8(1):49-63.
  5. http://dx.doi.org/10.1590/S1851-82652012000300011
  6. Instituto Nacional de Salud (INS). Guía Protocolo para la vigilancia en salud pública de leishmaniasis. Subdirección de Vigilancia y Control en Salud Pública. 2011; 1-29.
  7. Vélez ID, Zuleta, M. Geografía de la expansión de la Leishmaniasis en el conflicto armado en Colombia (Antioquia). Eu-topías 2013; 7:99-111.
  8. Romero M, Sánchez JA. Una mirada a la epidemiología y al control de la Leishmaniasis zoonótica en Colombia. Biosalud 2007; 6:99-111.
  9. Pennisi MG. Leishmaniosis of companion animals in Europe: An update. Vet Parasitol. 2015; 208(1-2):35-47.
  10. http://dx.doi.org/10.1016/j.vetpar.2014.12.023
  11. Vélez ID, Robledo SM. Leishmaniasis. Rev Leprol 2010; 27(4):367-396.
  12. The Center for Food Security & Public Health (CFSPH). Leishmaniasis (cutánea y visceral). Iowa state University. College of Veterinary Medicine. 2009; 1-13.
  13. Dalmau A, Ossó M, Oliva A, Anglada L, Sarobé X, Vives E. Leishmaniosis felina a propósito de un caso clínico. ¿Nos olvidamos de que existe?. Clin Vet Peq Anim 2008; 28(4):233-237.
  14. Rodríguez IE. Respuesta inmune a la infección por Leishmania infantum en caninos. REDVET. Revista Electrónica de Veterinaria 2009; 10(1):1-8.
  15. Rosypal A. Characterization of Canine Leishmaniasis in the United States: Pathogenesis, Immunological Responses, and Transmission of an American Isolate of Leishmania infantum. [Tesis Doctoral]. Virginia Polytechnic Institute & State University. EEUU. Blacksburg, VA; 2005.
  16. Baneth G, Koutinas A, Solano-Gallego L, Bourdeau P, Ferrer L. Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one. Trends Parasitol 2008; 24(7):324-330. http://dx.doi.org/10.1016/j.pt.2008.04.001
  17. Honse CO, Figueiredo FB, Alencar NX, Madeira MF, Gremião ID, Schubach TM. Disseminated intravascular coagulation in a dog naturally infected by Leishmania (Leishmania) chagasi from Rio de Janeiro – Brazil. Vet Res 2013; 9(43):1-5. http://dx.doi.org/10.1186/1746-6148-9-43
  18. Soares MJ, Moraes Jr, Moraes FR. Renal involvement in canine leishmaniasis: a morphological and immunohistochemical study. Arq Bras Med Vet Zootec 2009; 61(4):785-790.
  19. http://dx.doi.org/10.1590/S0102-09352009000400004
  20. Miró G. Leishmaniosis canina: situación actual en Europa, diagnóstico y control. Acta Scientiae Veterinariae 2007; 35(Supl 2):s227-s229.
  21. Pérez T, Marchesi D, Iglesias M. Primera Descripción del Uso de la Miltefosina en una Paciente con Leishmaniosis Canina, Infección Renal y Trichuris: Un Caso Complicado. Vet Arg 2009; XXVI(259):1-6.
  22. Miró G, Cardoso L, Grazia M, Oliva G, Baneth G. Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part two. Trends Parasitol 2008; 24(8):371-377.
  23. http://dx.doi.org/10.1016/j.pt.2008.05.003
  24. Chouihi E, Amri F, Bouslimi N, Siala E, Selmi K, Zallagua N, et al. Cultures on NNN medium for the diagnosis of leishmaniasis. Pathol Biol 2009; 57(3):219-24. http://dx.doi.org/10.1016/j.patbio.2008.03.007
  25. Roura, X. Diagnóstico y tratamiento de la leishmaniosis canina: actualización. Vet Arg 2012; 1-6.
  26. León M. Nuevos avances en la asociación antimoniato de meglumina + alopurinol: el tratamiento de referencia para la leishmaniosis canina. Consulta Difus Vet 2010; 173:37-39.
  27. Castagnaro M, Crotti A, Fondati A, Gradoni L, Lubas G, Maroli M, et al. Canine leishmaniasis: Guidelines for diagnosis, staging, therapy, monitoring and prevention.[on line]. Canine Leishmaniasis Working Group; 2007. URL Available in: http://www.gruppoleishmania.org/files/veterinaria_2007_eng.pdf
  28. Vásquez L, Vicu-a-Fernández N, Petit Y, López S, Scorza J, Scorza-Dager J, et al. Disposición farmacocinética de las especies de antimonio en perros después de una dosis de antimoniato de meglumina (Glucantime®). Bol Mal Salud Amb 2008; 48(1):27-33.
  29. Soto J, Soto P. Miltefosina oral para el tratamiento de la leishmaniasis. Biomédica 2006; 26(suppl.1):207-217.
  30. http://dx.doi.org/10.7705/biomedica.v26i1.1514
  31. Travi BJ, Tabares CJ, Cadena H. Leishmania (Viannia) braziliensis infection in two Colombian dogs: a note on infectivity for sand flies and response to treatment. Biomédica 2006; 26(Supl.1):249-53. http://dx.doi.org/10.7705/biomedica.v26i1.1520
  32. Rojas E, Morales C, Juárez E, Pineda N. Tratamiento de la leishmaniasis cutánea con plantas medicinales en Trujillo, Venezuela. Academia 2006; 19-25.
  33. Marques P. Alterações de proteinograma em canídeos com leishmaniose antes e após tratamento. [Tesis de Maestría]. Lisboa: Universidade Lusófona de Humanidades e Tecnologias; 2014.
  34. |Gómez-Ochoa P, Castillo JA, Gascó M, Zarate JJ, Alvarez F, Couto CG. Use of domperidone in the treatment of canine visceral leishmaniasis: A clinical trial. Vet J 2009; 179:259–263.
  35. http://dx.doi.org/10.1016/j.tvjl.2007.09.014
  36. Sabaté D, Llinás J, Homedes J, Sustc M, Ferrer L. A single-centre, open-label, controlled, randomized clinical trial to assess the preventive efficacy of a domperidone-based treatment programme against clinical canine leishmaniasis in a high prevalence area. Prev Vet Med 2014; 115:56–63.
  37. http://dx.doi.org/10.1016/j.prevetmed.2014.03.010
  38. Fernandes CB, Junior JT, de Jesus C, Souza BM, Larangeira DF, Fraga DB, et al. Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis. Vaccine 2014; 32(11):1287-1295.
  39. http://dx.doi.org/10.1016/j.vaccine.2013.12.046
  40. Wylie CE, Carbonell-Anto-anzas M, Aiassa E, Dhollander S, Zagmutt FJ, Brodbelt DC, Solano-Gallego L. A systematic review of the efficacy of prophylactic controlmeasures for naturally-occurring canine leishmaniosis, part I: Vaccinations. Prev Vet Med 2014; 117:7-18. http://dx.doi.org/10.1016/j.prevetmed.2014.06.016
  41. http://dx.doi.org/10.1016/j.prevetmed.2014.06.015
  42. Nevot C, Rosa A, Eiras D, Estévez O. Actualidad en Leishmaniasis Canina. Vet Arg 2013; XXX(305):1-8.
  43. Salomón OD, Mastrángelo AV, Santini MS, Ruvinsky S, Orduna T, Sinagra A, et al. Leishmaniasis visceral: senderos que confluyen, se bifurcan. Salud colectiva 2012; 8(supl.1):s49-s63.
  44. http://dx.doi.org/10.1590/S1851-82652012000300011
  45. Travi B. Ethical and epidemiological dilemmas in the treatment of dogs for visceral leishmaniasis in Latin America. Biomédica 2014; 34:7-12. http://dx.doi.org/10.7705/biomedica.v34i1.2153
  46. Passantino A, Russo M, Coluccio P. Canine leishmaniosis and eutanasia in Italy: a critical legal-ethical analysis. Rev Sci Tech 2010; 29(3):537-548.
  47. Wylie CE, Carbonell-Anto-anzas M, Aiassa E, Dhollander S, Zagmutt FJ, Brodbelt DC, Solano-Gallego L. A systematic review of the efficacy of prophylactic control measures for naturally occurring canine leishmaniosis. Part II: Topically applied insecticide treatments and prophylactic medications. Prev Vet Med 2014; 117:19-27. http://dx.doi.org/10.1016/j.prevetmed.2014.06.016
  48. Organización Mundial de la Salud (OMS). Control de la leishmaniasis. [on line] 2010. Serie de Informes Técnicos. URL Valida en: http://apps.who.int/iris/bitstream/10665/82766/1/WHO_TRS_949_spa.pdf

Sistema OJS 3.4.0.3 - Metabiblioteca |